Publication | Closed Access

Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients

Aspirin/antiplatelet Agent UseBreast OncologyMedicinePharmacologyBreast CancerPharmacotherapyDistant MetastasesDisease-free SurvivalCancer TreatmentPlatelet AntagonistOncology